程永清,沙志涛,田有勇

• 1:南京医科大学附属南京医院(南京市第一医院)神经内科

摘要(Abstract)：

既往早期帕金森病(PD)的诊断主要依赖临床表现,但随着人们对疾病认识的深入及影像学尤其是功能影像学的发展,以单光子发射计算机断层显像(SPECT/CT)、正电子发射计算机断层显像(PET/CT)、磁共振成像(MRI)及经颅超声显像(TCS)等为代表的影像技术在PD早期诊断方面体现出了极大的价值。现就PD的影像学诊断研究进展进行综述。

关键词(KeyWords)： 帕金森病;诊断;影像学

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 程永清,沙志涛,田有勇

DOI: 10.16780/j.cnki.sjssgncj.2016.02.019

参考文献(References)：

• [1]Berg D,Lang AE,Postuma RB,et al.Changing the research criteria for the diagnosis of Parkinson’s disease:obstacles and opportunities[J].Lancet Neurol,2013,12:514-524.
• [2]Perlmutter JS,Norris SA.Neuroimaging biomarkers for Parkinson disease:Facts and fantasy[J].Ann Neurol,2014,76:769-783.
• [3]Wang J,Hoekstra JG,Zuo C,et al.Biomarkers of Parkinson’s disease:current status and future perspectives[J].Drug Discov Today,2013,18:155-162.
• [4]Jennings DL,Seiby JP,Oakes D,et al.(123I)beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome:unmasking an early diagnosis[J].Arch Neurol,2004,61:1224-1229.
• [5]Ba F,Martin WR.Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice[J].Parkinsonism Relat Disord,2015,21:87-94.
• [6]Marek K,Seiby J,Eberly S,et al.Longitudinal follow-up of SWEDD subjects in the PRECEPT Study[J].Neurology,2014,82:1791-1797.
• [7]Kordower JH,Olanow CW,Dodiya HB,et al.Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease[J].Brain,2013,136:2419-2431.
• [8]de Verdal M,Rendrd D,Collombier L,et al.I123-FP-CIT single-photon emission tomography in patients with long-standing mixed tremor[J].Eur J Neurol,2013,20:382-388.
• [9]Roberto C.Carlo R,Daniela F,et al.Dopamine transporter SPECT imaging in corticobasal syndrome[J].PLo S One,2011,6:e18301.
• [10]Perju-Dumbrava LD,Koyacs GG,Susanne P,et al.Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy[J].Mov Disord,2012,27:65-71.
• [11]Stéphane L,Enic B,Cyril P,et al.7 tesla magnetic resonance imaging:A closer look at substantia nigra anatomy in Parkinson's disease[J].Mov Disord,2014,29:1574-1581.
• [12]Tambasco N,Nigro P,Romoli M,et al.Magnetization transfer MRI in dementia disorders,Huntington's disease and parkinsonism[J].J Neurol Sci,2015,353:1-8.
• [13]Meijer FJ,van Rumund A,Fasen BA,et al.Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of Parkinsonism[J].AJNR Am J Neuroradiol,2015,36:454-460.
• [14]Sch覿fer A,Forstmann BU,Neumann J,et al.Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping[J].Hum Brain Mapp,2012,33:2831-2842.
• [15]康德智,王芳玉,陈富勇,等,帕金森病患者静息态功能磁共振的研究[J].中华神经医学杂志,2015,14:136-140.
• [16]Jon SA,Stephane L,Stofella AP.Imaging insights into basal ganglia function,Parkinson's disease,and dystonia[J].Lancet,2014,384:532-544.
• [17]Nadya P,Cécile G,Daniel GL,et al.A review of the use of magnetic resonance imaging in Parkinson's disease[J].Ther Adv Neurol Disord,2014,7:206-220.
• [18]王珲,唐荣华,马育林,等,磁共振扩散张量成像及波谱分析在帕金森病早期诊断中的应用[J].神经损伤与功能重建,2015,10:46-49.
• [19]Gaenslen A,Unmuth B,Godau J,et al.The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease:a prospective blinded study[J].Lancet Neurol,2008,7:417-424.
• [20]Berardelli A,Wenning GK,Antonini A,et al.EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease[J].Eur J Neurol,2013,20:16-34.
• [21]Berg D,Godau J,Walter U.Transcranial sonography in movement disorders[J].Lancet Neurol,2008,7:1044-1055.
• [22]Bor-Seng-Shu E,Pedroso JL,Andrade DC,et al.Transcranial sonography in Parkinson's disease[J].Einstein,2012,10:242-246.
• [23]Bouwmans AEP,Vlaar AMM,Mess WH,et al.Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease:prospective cohort study in 196 patients[J].BMJ Open,2013,3:70-71.
• [24]Liu P,Li X,Li FF,et al.The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease:Comparison with DAT PET scans[J].Neurosci Lett,2014,582:99-103.
• [25]Schweitzer KJ,Hilker R,Walter U,et al.Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson’s disease[J].Mov Disord,2006,21:94-98.
• [26]Huang YW,Jeng JS,Tsai CF,et al.Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson’s disease[J].Mov Disord,2007,22:550-555.